🇺🇸 FDA

Drug profile · INN

budesonide

BIRESP SPIROMAX

approved A07EA06
US status
approved
Patents linked
5
News articles
0

Quick answer

budesonide (BIRESP SPIROMAX) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: rectal. Current US regulatory status: approved.

Key facts

INN budesonide
Brand BIRESP SPIROMAX
Route RECTAL
Formulation AEROSOL, FOAM
ATC code A07EA06

Related patents

Search patents →

Frequently asked questions

What is budesonide?

budesonide (BIRESP SPIROMAX) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: rectal. Current US regulatory status: approved.

What is the brand name for budesonide?

BIRESP SPIROMAX is a marketed brand name for budesonide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of budesonide?

budesonide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.